Last updated on April 2020

A Phase II Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma


Find a site near you

Start Over

Washington University

Saint Louis, MO United States
  Connect »

MD Anderson Cancer Center

Houston, TX United States
  Connect »

Mayo Clinic - Jacksonville

Jacksonville, FL United States
  Connect »

University of Michigan

Ann Arbor, MI United States
  Connect »

Seattle Children's Hospital

Seattle, WA United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.